4559:TYO
Zeria Pharmaceutical Co Ltd
1 925,00 JPY
arrow_downward
-0,21%(-4,00) 1 d.
9. 10., 15:30:00 GMT+9 · JPY
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 4559…
Otvoriť
1 923 JPY
Vysoká
1 940 JPY
Nízka
1 919 JPY
Trh. kap.
96,48 mld.
Priem. obj.
170,22 tis.
Objem
77,50 tis.
Dividenda
2,55 %
Štvrťročná dividenda
12 JPY
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Pomer cena/zárobky
10,31
Max. za 52 týž.
2 434 JPY
Min. za 52 týž.
1 878 JPY
Výnosy na akciu
187 JPY
Akcie v obehu
50,11 mil.
Počet zamestnancov
2 tis.
Otvoriť
1 923 JPY
Vysoká
1 940 JPY
Nízka
1 919 JPY
Trh. kap.
96,48 mld.
Priem. obj.
170,22 tis.
Objem
77,50 tis.
Dividenda
2,55 %
Štvrťročná dividenda
12 JPY
Prvý obchodný deň po vyplatení dividendy
29. 9. 2026
Pomer cena/zárobky
10,31
Max. za 52 týž.
2 434 JPY
Min. za 52 týž.
1 878 JPY
Výnosy na akciu
187 JPY
Akcie v obehu
50,11 mil.
Počet zamestnancov
2 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
MarketBeat
·
pred 48 minútami
Axiom Intelligence Acquisition Corp 1 (NASDAQ:AXIN) Stock Short Interest Drops 85.7%
MarketWatch
·
pred 51 minútami
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
ChartMill
·
pred 1 hodinou
XPEL (NASDAQ:XPEL): A GARP Stock with Profitable Growth and Reasonable Valuation
Seeking Alpha
·
pred 3 hodinami
S&P 500 Index Concentration - Room At The Top
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Informácie o subjekte Zeria Pharmaceutical Co Ltd
Generálny riaditeľSachiaki Ibe
Zamestnanci1,75 tis.
Dátum založenia22. 12. 1955
Hlavné sídlo-
Odvetvie-
Webzeria.co.jp